Category: Biocide

This is the default blog subtitle.

Call of interest to join the eu registration group for chrysanthemum (pyrethrum)-based biocidal products

Call of interest to join the eu registration group for chrysanthemum (pyrethrum)-based biocidal products

In order to fulfil the required regulatory obligations under the BPR in respect to the Biocidal Products that are currently in the EU market containing the Active Substance, Chrysanthemum cinerariaefolium, CAS nº: 89997-63-7, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents and obtained with supercritical CO2 Manufacturers and Distributors have […]

Read More

Treated Articles with added biocidal functionality

Treated Articles with added biocidal functionality

Are they correctly labelled? Is there any human risk derived from their use? How can their efficacy be measured? Treated Articles that incorporate a biocidal product with the intention to add new properties or functions to this article, not related to its primary use, are Biocidal Products themselves, for example: Antibacterial clothing Keyboard treated to […]

Read More

Latest BPC opinions on disinfectants and wood preservatives

Latest BPC opinions on disinfectants and wood preservatives

The EU Biocidal Products Committee adopted opinions for the following disinfectant active substances that may be approved/renewed in the relevant product-types: Didecyldimethylammonium chloride (CAS No. 7173-51-5) for product-types 3 and 4; Alkyl (C12-16) dimethylbenzyl ammonium chloride (CAS No. 68424-85-1) for product-types 3 and 4; N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine (CAS No. 2372-82-9) for product-type 8; Ethylene oxide (CAS No. […]

Read More

Hypochlorous acid approved in Europe as PT1, PT2, PT3 and PT4 (CAS no. N.o CAS: 7790-92-3)

Hypochlorous acid approved in Europe as PT1, PT2, PT3 and PT4 (CAS no. N.o CAS: 7790-92-3)

The EU Commission has recently published the Implementing Regulations that approve the biocidal active substance “Active chlorine release from hypochlorous acid” with CAS number 7790-92-3, where the following dates have been stated for the submission of the BPR Dossiers: →        PT1 (Regulation 2021/365): 1st July 2021 →        PT2, 3 and 4 (Regulation 2021/347): 1st July […]

Read More

Food Attractant Active Substances – June 2021 deadline for EU Dossier submision

Food Attractant Active Substances – June 2021 deadline for EU Dossier submision

Biocidal products with attractant function based on the following active substances of food grade (proposed for inclusion in Annex I of the BPR) need to be supported by an EU Dossier under BPR and the deadline for this submission is June 2021: Cheese Concentrated Apple juice D-Fructose (CAS No. 57-48-7) Honey (CAS No. 8028-66-8) Powdered […]

Read More

Call of interest to join the PT2 Painting Products Consortia

Call of interest to join the PT2 Painting Products Consortia

Painting Products used to modify the surfaces that are treated in the sense to protect them from the development of undesired microorganisms, come under the Biocidal Product Regulation (BPR). Depending on the active substances present in the Biocidal Products, whether they are still under EU revision or they are approved, different procedures need to be […]

Read More

Call of interest to join the Ethanol-based Products Consortia

Call of interest to join the Ethanol-based Products Consortia

Sanitising products, such as hand sanitisers, come under the Biocidal Product Regulation (BPR). The most common active substance used in hand sanitisers is Ethanol. Ethanol is currently being reviewed as a biocide active substance in the EU by Greece and no tentative date for approval is known now, so Biocidal products containing Ethanol fall under […]

Read More

EU Commission Measures during Covid-19 Pandemic and Regulatory Deadlines

EU Commission Measures during Covid-19 Pandemic and Regulatory Deadlines

Please see below the latest measures taken by the EU Commission related to regulatory issues during Covid-19 Pandemic: The Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the COVID-19 pandemic. The Commission welcomes the adoption by the European Parliament and the Council of the proposal to […]

Read More